Autism is an etiologically heterogeneous group of neurodevelopmental disorders, diagnosed mostly by the clinical behavioral phenotypes. The concept that the tumor-related gene PTEN plays a critical role in autism spectrum disorder has emerged over the last decade. In this review, we focus on the essential role of the PTEN signaling pathway in neuronal differentiation and the formation of neural circuitry, as well as genetic mouse models with Pten manipulations. Particularly, accumulated data suggest that the effect of PTEN on neural stem-cell development contributes signifi cantly to the pathophysiology of autism spectrum disorders.
Introduction
The phosphatase and tensin homolog (PTEN) gene on chromosome 10 was initially identified as a tumorsuppressor gene that is frequently mutated in human cancers. Further studies showed that PTEN plays an important role in brain development [1, 2] . Human genetic studies showed that PTEN germline mutations result in macrocephaly, seizures, and mental retardation [2] [3] [4] .
Biochemical studies showed that PTEN negatively regulates the phosphatidylinositol-3-kinase (PI3K)/AKT signaling pathway [1] (Fig. 1A) . Its lipid phosphatase function directly counteracts PI3K activity, thereby inhibiting the activation of AKT. The PI3K/AKT pathway is indispensable for regulating cell growth, survival, and proliferation.
Therefore, abnormalities in the PI3K/AKT/mTOR pathway lead to neurological and psychiatric disorders such as brain tumors, autism, and schizophrenia.
A component of the PI3K/AKT pathway, tuberous sclerosis complex 1/2 (TSC1/2) was initially identified as a tumor-suppressor, but further studies found that it is essential for normal brain development and function. TSC1
interacts with TSC2 to form a dimer that has physiological functions. TSC1/TSC2 inhibit mammalian target of rapamycin complex 1 (mTORC1), which is a regulatory factor for mitotic cell growth, and this suppression is released by AKT-mediated TSC2 dephosphorylation [5] [6] [7] ( Fig. 1A) .
Autism spectrum disorders (ASDs) include a variety of neurodevelopmental symptoms [8] . They affect ~7 per 1 000 children and are marked by impaired social relationships, communication deficits, and stereotyped and repetitive behaviors. Seventy percent of ASD cases are associated with mental retardation [9] [10] [11] . Still, the genetic basis of ASDs remains largely unknown. So far, hundreds of genes and many chromosome regions have been proposed to be associated with ASDs. In this review, we summarize the recent genetic and neurobiological fi ndings and hypothesize that the PTEN signaling pathway plays a critical role in the pathophysiology of ASD, ranging from multiple aspects of neural development such as neurogenesis, synapseformation and plasticity, to the structural and functional plasticity of neural circuitry (Table 1) . We also discuss available mouse models with genetic manipulations involving the PTEN signaling pathway. Disorder ASD with macrocephaly [12] Tuberous sclerosis complex [13] [14] [15] Rate of autism 1-17% [16] ~25-60% [13] [14] [15] Rate in autism 1% [16] 1.1-1.3% [17] [18] [19] Synapse development Overgrowth [20, 21] Hypertrophy [22] Animal models Macrocephaly, social behavior defi cits, seizures, Macrocephaly, seizures, learning anxiety, learning defi cits [20] and memory defi cits, anxiety [23, 24] Genetic Mutations of the PTEN Signaling Pathway
in ASD Patients
Studies of PTEN mutation frequency in ASD patients show discrepancies across different studies most likely due to genetic variations among populations. Geneticists have screened the PTEN mutations in children diagnosed with autism and macrocephaly independently, and reported that their frequency is ~1% [16] , 8.3% [25] and 17% [12] . The head circumference of the included children and whether they were from simplex or multiplex families may explain the inconsistencies among studies. Autism with extreme or familial macrocephaly may have a much higher PTEN mutant rate [12] . When Buxbaum et al. undertook PTEN gene mutation analysis in patients with ASDs and macrocephaly, they showed ~1% PTEN mutations in all participants with macrocephaly from multiplex families, who were the only macrocephalic individuals in the family [16] . In the future, more comprehensive analysis of the PTEN gene in a greater number of patients with autism would give a more complete picture of the prevalence of PTEN mutations in autistic people. Moreover we still need to consider the possibilities that a reduction in PTEN level may occur either by genetic mutation or by epigenetic mechanisms within specific brain regions, which would not be detectable in peripheral blood samples [26] .
Either TSC1 or TSC2 gene mutation causes human tuberous sclerosis complex (TSC) and 25-50% of these patients exhibit phenotypes related to ASD [13] [14] [15] . In patients diagnosed with ASD, 1.1-1.3% have TSC [17] [18] [19] . Children with TSC and TSC2 mutations are more likely to develop autism than those carrying TSC1 mutations. Children with TSC2 mutations are more likely to be diagnosed with autism if they show early-onset infantile spasms and temporal lobe tubers screened by MRI [27] . In one study, Jeste et al. showed that ~50% of children with TSC have autistic phenotypes, based on the Autism Diagnostic Observation Schedule (more specifi cally 66% at 1.5 years of age, 54% at 2 years, 46% at 3 years, and 50% at 5 years) [28] . Furthermore, the cognitive functions of children with TSC and ASD phenotypes are more severely impaired than those without autism [28] .
Role of the PTEN Pathway in Neuronal Fate

Determination and Differentiation
Brain-specific Pten-deficient mice provide a good model to investigate the role of PTEN in the proliferation and differentiation of neural stem/progenitor cells (NSCs) [29, 30] .
The mouse brain becomes abnormally large when Pten is deleted from embryonic NSCs. Further analysis showed that this results from increased cell proliferation, reduced apoptosis, and cellular enlargement [29] . Independent studies have shown that adult NSCs are regulated by PTEN in the subventricular zone of the lateral ventricles [30] .
However, using in vivo clonal analysis, researchers found that Pten deficiency in quiescent nestin-GFAPexpressing radial glia-like precursor cells in the adult subgranular zone exhausts the pool of these cells, and this is achieved by accelerated terminal differentiation of astrocytes within 30 days [31] . Similarly, another study while more astrocytes, rather than neurons, were derived from newborn cells in the hippocampus after four months of Pten deletion [32] . Both studies showed that Pten deletion in NSCs initially causes an increase in proliferation and the subsequent exhaustion of NSCs [33] (Fig. 1B) .
In vivo experiments showed that NSCs with Tsc1
deletion increase in size with enlarged vacuoles [34] . The proliferation of NSCs increases with Tsc1 disruption [35] . In addition, Tsc1-null NSCs in the lateral ventricle result in deregulated aggregation and migration [36] . Furthermore, NSCs with Tsc1 disruption form subependymal nodules and subependymal giant-cell astrocytomas, which are regular characteristics of the TSCs. Furthermore, they found that the loss of Tsc1 in cultured NSCs does not result in evident changes in morphology or proliferation [36] .
Role of the PTEN Signaling Pathway in Dendritic and Synaptic Development
Conditional Pten knock-out mice have been used to study
Pten in the nervous system [29, [37] [38] [39] [40] [41] . Mice with Pten deletion in mature neurons of the cerebral cortex and hippocampus have macrocephaly, while the growth of dendrites and axons and the number of synapses are impaired. In vitro and in vivo studies showed that loss of Pten in neurons leads to neuronal hypertrophy with somatic, dendritic, and axonal overgrowth [20, 21] . The dendritic over-growth is further reflected by increased dendritic arborization, increased dendritic caliber, and increased number of dendritic spines.
Pten is also involved in the regulation of neuronal polarity;
disrupting Pten function leads to multiple ectopic axons and loss of proper axonal projections [20, 42] . Furthermore,
Luikart et al. recently developed a virus-based strategy
that allows in vivo knockdown of Pten specifi cally in mouse hippocampal granule cells [43] ; they found that granule cells with Pten knockdown have a preferential increase in excitatory synaptic functions. A recent study has also
shown that Pten overexpression results in reduced spine density, which depends on protein phosphatase activity [44] .
Thus, attenuating Pten function in neurons has profound effects on neuronal morphology and circuitry. Interestingly, whether the protein or phospholipid phosphatase activity of Pten contributes to different physiological outcomes needs to be further addressed.
Previous studies have shown that TSC1/2 disruption or hyperactivation of mTORC1 results in neuronal hypertrophy.
Importantly, a recent study demonstrated that lack of either TSC1 or TSC2 in neurons also promotes ectopic axonformation [23, 45] . Tsc1/2 mutations are suspected to result in mTORC1 overactivation. Thus, it has been proposed that Neurosci Bull December 1, 2013, 29(6): 773-778 776 hyperactivation of the mTOR pathway results in increased synaptic protein synthesis, thereby giving rise to abnormal synaptic function [46] .
Role of the PTEN Signaling Pathway in Synaptic Plasticity
To investigate the role of PTEN in mature neuronal circuitry, Chow et al. used chronic in vivo imaging to trace the changes of pyramidal neurons before and after Pten knockout in the cortex of adult mice [47] . They found that the apical dendrites of layers II/III pyramidal neurons in Ptennull mice became longer and more tortuous, whereas spine density was significantly reduced along more distal dendritic regions. Interestingly, the apical dendrites of layer V pyramidal neurons in Pten-null mice appeared normal, and dendritic growth, spine density, and spine dynamics did not change, suggesting that PTEN plays a distinct role in different neuronal populations in adult circuitry [47] .
Tavazoie et al. showed that in the hippocampal pyramidal neurons of rodents, the TSC pathway is essential for the regulation of soma size, dendritic spine density and size, and excitatory synaptic properties [45] . Loss of Tsc1 leads to increased size but decreased density of dendritic spines. Tsc1 disruption increases AMPAR-mediated synaptic currents. Neuronal morphology is sensitive to hemizygosity of Tsc1. Bateup et al. knocked out Tsc1 in the hippocampal CA1 neurons of mice after birth. They found that metabotropic glutamate receptor-dependent longterm depression, which depends on protein translation, is not detectable in Tsc1-knockout neurons [22] . There are no clear abnormalities in dendritic spine number, morphology, or presynaptic release probability with Tsc1 knockout [22] . This evidence suggests that PTEN and TSC signaling pathways play central roles in the structural and functional plasticity of adult cortical and hippocampal neural circuitry.
Genetic Mouse Models in ASD Studies
Pten knockout mice die in the early embryonic period, and heterozygous mice are susceptible to a variety of tumors, including prostate cancer, endometrial cancer, and lymphoid tumors [48] . Pten deletion enhances the proliferation of T-lymphocytes, mammary epithelial cells, NSCs, and astrocytes [29, 40, 49, 50] , and hypertrophy is induced in granule neurons, cardiomyocytes, and the cerebellum [38, 51] . Kwon et al. ablated Pten expression specifically in a subset of post-mitotic neurons in mouse hippocampus and cortex.
These mice develop macrocephaly, and display behavioral phenotypes which resemble human autism, including social behavior defi cits, seizures, elevated anxiety, and learning defi cits [20] .
Consistent with the Pten deletion phenotypes, knocking out Tsc1/2 broadly in the brain results in macrocephaly and seizures [23, 24] . In addition, Tsc2 heterozygous mice with elevated mTORC1 activity in the brain show deficits in learning and memory [52] , and Tsc2 dominant-negative transgenic mice show increased anxiety [53] . Thus, disrupting TSC1/2 complex function in the nervous system mimics the cellular effects of PTEN loss, and loss of Tsc1/2 in the brain results in behavioral defects similar to PTEN ablation.
Together, these data indicate that the TSC1/2 complex is a major component mediating the cellular and behavioral changes observed in Pten mutants.
Further studies showed that the specific mTORC1 inhibitor rapamycin can prevent and reverse the enlargement of neurons and improve the abnormal behaviors caused by
Pten deletion [54] . These results strongly suggest that PTEN-TSC1/2 pathway dysfunction causes autistic phenotypes and correction of the signal pathway reverses some abnormal phenotypes, providing a potential strategy for the treatment of ASDs. 
Perspectives and Remaining Questions
